The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
Open accessAbstract
Immunogenic, broadly reactive epitopes of the HIV-1 envelope glycoprotein could serve as important targets of the adaptive humoral immune response in natural infection and, potentially, as components of an acquired immune deficiency syndrome vaccine. However, variability in exposed epitopes and a combination of highly effective envelope-cloaking strategies have made the identification of such epitopes problematic. Here, we show that the chemokine coreceptor binding site of HIV-1 from clade A, B, C, D, F, G, and H and circulating recombinant form (CRF)01, CRF02, and CRF11, elicits high titers of CD4-induced (CD4i) antibody during natural human infection and that these antibodies bind and neutralize viruses as divergent as HIV-2 in the presence of soluble CD4 (sCD4). 178 out of 189 (94%) HIV-1–infected patients had CD4i antibodies that neutralized sCD4-pretreated HIV-2 in titers (50% inhibitory concentration) as high as 1:143,000. CD4i monoclonal antibodies elicited by HIV-1 infection also neutralized HIV-2 pretreated with sCD4, and polyclonal antibodies from HIV-1–infected humans competed specifically with such monoclonal antibodies for binding. In vivo, variants of HIV-1 with spontaneously exposed coreceptor binding surfaces were detected in human plasma; these viruses were neutralized directly by CD4i antibodies. Despite remarkable evolutionary diversity among primate lentiviruses, functional constraints on receptor binding create opportunities for broad humoral immune recognition, which in turn serves to constrain the viral quasispecies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Self-citationKwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Self-citationAntibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationThe HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Self-citationRapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Self-citationKwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Self-citationA Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Self-citationZwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Self-citationBinley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
Expression cloning of new receptors used by simian and human immunodeficiency viruses
Deng, H., Unutmaz, D., KewalRamani, V. N., & Littman, D. R. (1997) · Nature · doi:10.1038/40894 · Cited by 684
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Self-citationThali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Self-citationBUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa
Gao, F., Yue, L., White, A. T., Pappas, P. G., Barchue, J., Hanson, A. P., Greene, B. M., Sharp, P. M., Shaw, G. M., & Hahn, B. H. (1992) · Nature · doi:10.1038/358495a0 · Cited by 507
Self-citationMoore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Self-citationDynamics of HIV-1 recombination in its natural target cells
Levy, D. N., Aldrovandi, G. M., Kutsch, O., & Shaw, G. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306764101 · Cited by 441
Self-citationMascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Robertson, D. L., Hahn, B. H., & Sharp, P. M. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00163230 · Cited by 423
Self-citationWyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Self-citationAlbert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nyström, G., & Fenyö, E. M. (1990) · AIDS · doi:10.1097/00002030-199002000-00002 · Cited by 398
Human immunodeficiency virus type 2
Reeves, J. D., & Doms, R. W. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-6-1253 · Cited by 369
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Self-citationA Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
PURTSCHER, M., TRKOLA, A., GRUBER, G., BUCHACHER, A., PREDL, R., STEINDL, F., TAUER, C., BERGER, R., BARRETT, N., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1651 · Cited by 347
Identifying epitopes of HIV-1 that induce protective antibodies
Zolla-Pazner, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1307 · Cited by 326
Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S., & Montefiori, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/516508 · Cited by 326
Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F., & Poignard, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7383-7393.1993 · Cited by 317
Huang, C.-C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M.-Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308527100 · Cited by 275
Self-citationStable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein
Hoffman, T. L., LaBranche, C. C., Zhang, W., Canziani, G., Robinson, J., Chaiken, I., Hoxie, J. A., & Doms, R. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6359 · Cited by 263
Self-citationThe neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Moog, C., Fleury, H. J., Pellegrin, I., Kirn, A., & Aubertin, A. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3734-3741.1997 · Cited by 232
Barnett, S. W., Lu, S., Srivastava, I., Cherpelis, S., Gettie, A., Blanchard, J., Wang, S., Mboudjeka, I., Leung, L., Lian, Y., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5526-5540.2001 · Cited by 216
Self-citationChoe, H., Li, W., Wright, P. L., Vasilieva, N., Venturi, M., Huang, C.-C., Grundner, C., Dorfman, T., Zwick, M. B., Wang, L., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00508-7 · Cited by 214
Self-citationGorry, P. R., Taylor, J., Holm, G. H., Mehle, A., Morgan, T., Cayabyab, M., Farzan, M., Wang, H., Bell, J. E., Kunstman, K., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6277-6292.2002 · Cited by 212
Xiang, S.-H., Kwong, P. D., Gupta, R., Rizzuto, C. D., Casper, D. J., Wyatt, R., Wang, L., Hendrickson, W. A., Doyle, M. L., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9888-9899.2002 · Cited by 178
Self-citationIncreased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants
Kolchinsky, P., Kiprilov, E., & Sodroski, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2041-2050.2001 · Cited by 171
Kolchinsky, P., Kiprilov, E., Bartley, P., Rubinstein, R., & Sodroski, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3435-3443.2001 · Cited by 163
Zhang, Y.-J., Lou, B., Lal, R. B., Gettie, A., Marx, P. A., & Moore, J. P. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6893-6910.2000 · Cited by 160
Rizzuto, C. D., & Sodroski, J. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200308747 · Cited by 159
Kolchinsky, P., Mirzabekov, T. A., Farzan, M., Kiprilov, E., Cayabyab, M. J., Mooney, L. J., Choe, H., & Sodroski, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8120-8126.1999 · Cited by 152
Cormier, E. G., Tran, D. N. H., Yukhayeva, L., Olson, W. C., & Dragic, T. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5541-5549.2001 · Cited by 138
Enhanced Expression, Native Purification, and Characterization of CCR5, a Principal HIV-1 Coreceptor
Mirzabekov, T. A., Bannert, N., Farzan, M., Hofmann, W., Kolchinsky, P., Wu, L., Wyatt, R. T., & Sodroski, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28745 · Cited by 134
Salzwedel, K., Smith, E. D., Dey, B., & Berger, E. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.326-333.2000 · Cited by 132
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx
Wu, X., Liu, H., Xiao, H., Kim, J., Seshaiah, P., Natsoulis, G., Boeke, J. D., Hahn, B. H., & Kappes, J. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3389-3398.1995 · Cited by 125
Self-citationFOUTS, T. R., Tuskan, R. G., Godfrey, K., Reitz, M. S., Hone, D. M., Lewis, G. K., & DeVico, A. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11427-11436.2000 · Cited by 115
McGaughey, G. B., Citron, M. P., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M. D., Shiver, J. W., et al. (2003) · Biochemistry · doi:10.1021/bi026952u · Cited by 103
Montefiori, D. C., Hill, T. S., Vo, H. T. T., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10200-10207.2001 · Cited by 90
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate
Kumar, P., Hui, H., Kappes, J. C., Haggarty, B., Hoxie, J. A., Arya, S. K., Shaw, G. M., & Hahn, B. H. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.890-901.1990 · Cited by 87
Self-citationLiang, X., Munshi, S., Shendure, J., Mark, G., Davies, M. E., Freed, D. C., Montefiori, D. C., & Shiver, J. W. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00125-5 · Cited by 84
Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia
Schulz, T. F., Whitby, D., Hoad, J. G., Corrah, T., Whittle, H., & Weiss, R. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.5177-5182.1990 · Cited by 80
Zhang, P. F., Bouma, P., Park, E. J., Margolick, J. B., Robinson, J. E., Zolla‐Pazner, S., Flora, M. N., & Quinnan, G. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.644-655.2002 · Cited by 79
Self-citationXiang, S.-H., Wang, L., Abreu, M., Huang, C.-C., Kwong, P. D., Rosenberg, E. S., Robinson, J. E., & Sodroski, J. (2003) · Virology · doi:10.1016/s0042-6822(03)00521-x · Cited by 78
Self-citationPugach, P., Kuhmann, S. E., Taylor, J., Marozsan, A. J., Snyder, A., Ketas, T. J., Wolinsky, S. M., Korber, B., & Moore, J. P. (2004) · Virology · doi:10.1016/j.virol.2003.12.012 · Cited by 77
Salzwedel, K., & Berger, E. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230438497 · Cited by 73
Liao, H., Alam, S. M., Mascola, J. R., Robinson, J. E., Ma, B., Montefiori, D. C., Rhein, M. E., Sutherland, L. L., Scearce, R. M., & Haynes, B. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5270-5278.2004 · Cited by 38
Self-citationColman, P. M. (1997) · Structure · doi:10.1016/s0969-2126(97)00214-1 · Cited by 29
Structural Studies on Antibody Interacting with Viruses
Hewat, E. A., & Blaas, D. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_2 · Cited by 11
Cited by
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationSalazar-Gonzalez, J. F., Salazar, M. G., Keele, B. F., Learn, G. H., Giorgi, E. E., Li, H., Decker, J. M., Wang, S., Baalwa, J., Kraus, M. H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090378 · Cited by 764
Self-citationTomaras, G. D., Yates, N. L., Liu, P., Qin, L., Fouda, G. G., Chavez, L. L., Decamp, A. C., Parks, R. J., Ashley, V. C., Lucas, J. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01708-08 · Cited by 631
Self-citationHuman Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Self-citationGP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Metadata
- Authors
- Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., Hunter, E., Saag, M. S., Hoxie, J. A., Hahn, B. H., Kwong, P. D., Robinson, J. E., & Shaw, G. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-05-02
- Volume
- 201
- Issue
- 9
- Pages
- 1407-1419
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2128461524
- Cited by
- 295
- References
- 61
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.